Skip to main content

Table 3 Intraoperative outcomes

From: Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index

Variable

1st CRS

2nd CRS

Time to ORa (days)

109 [22–216]

111 [90–212]

PCI

33 [29–39]

21 [15–39]

CRS performed

8 (100)

7 (87.5)

HIPEC performed

0 (0)

7 (87.5)

Resection

 Hollow viscera

2 [1–3]

1 [0–2]

 Solid viscera

2 [0–3]

2 [0–3]

Anastomoses

1 [1–2]

0 [0–2]

Completeness of cytoreduction

 0

0 (0)

5 (55.6)

 1

0 (0)

3 (33.3)

 2

8 (100)

0 (0)

 Not resectable

0 (0)

1 (11.1)

Duration of procedure (min)

420 [180–530]

480 [180–660]

Estimated blood loss (mL)

800 [300–4000]

1100 [500–2700]

n patient transfused

3 (37.5)

5 (62.5)

  1. Values are presented as median [range] or n (%)
  2. CRS cytoreductive surgery, OR operating room, PCI Peritoneal Cancer Index, HIPEC hyperthermic intraperitoneal chemotherapy
  3. aTime from diagnosis to 1st CRS, and time from 1st to 2nd CRS, respectively